Research News

Published in:
Volume 10 / Year 2021 / Issue 3

Biosimilar epoetin for cancer and chemotherapy-induced anaemia in the US

Page: 122

Biosimilars are biological drug products that are highly similar to reference products in analytic features, pharmacokinetics and pharmacodynamics, immunogenicity, safety and efficacy. Biosimilar epoetin received US Food and Drug Administration… Read More »

Go Back Print